Overview
EDSA market data
Price History
EDSA price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for EDSA. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Edesa Biotech shares are trading higher after the company announced a $3.5 million private placement of common shares.Benzinga · Jun 11, 2026, 5:06 PM
8-K filing — Edesa Biotech, Inc. (EDSA)SEC EDGAR · Jun 11, 2026, 1:20 PM
Edesa Biotech Announces Exploratory Data For Its Anti-TLR4 Monoclonal Antibody Paridiprubart In Patients With Acute Kidney Injury And Respiratory Distress; Analyses Demonstrate Mortality ReductionBenzinga · Jun 5, 2026, 1:30 PM
Acute Respiratory Distress Syndrome Market to Grow Steadily at a 3.8% CAGR Through 2036, Supported by Emerging ARDS Therapies | DelveInsightGlobenewswire Inc · Jun 3, 2026, 5:15 PM
Edesa Biotech Q2 EPS $(0.49) Misses $(0.26) EstimateBenzinga · May 14, 2026, 8:50 PM